These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9. Peng CC; Rushmore T; Crouch GJ; Jones JP Bioorg Med Chem; 2008 Apr; 16(7):4064-74. PubMed ID: 18255300 [TBL] [Abstract][Full Text] [Related]
5. Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach. Tarcsay A; Kiss R; Keseru GM J Comput Aided Mol Des; 2010 May; 24(5):399-408. PubMed ID: 20361237 [TBL] [Abstract][Full Text] [Related]
6. Prediction of metabolism by cytochrome P450 2C9: alignment and docking studies of a validated database of substrates. Sykes MJ; McKinnon RA; Miners JO J Med Chem; 2008 Feb; 51(4):780-91. PubMed ID: 18237107 [TBL] [Abstract][Full Text] [Related]
7. Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Zhou SF; Zhou ZW; Yang LP; Cai JP Curr Med Chem; 2009; 16(27):3480-675. PubMed ID: 19515014 [TBL] [Abstract][Full Text] [Related]
8. The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidation. Nair PC; Burns K; Chau N; McKinnon RA; Miners JO J Biol Chem; 2023 Dec; 299(12):105368. PubMed ID: 37866634 [TBL] [Abstract][Full Text] [Related]
10. Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations. Hutzler JM; Wienkers LC; Wahlstrom JL; Carlson TJ; Tracy TS Arch Biochem Biophys; 2003 Feb; 410(1):16-24. PubMed ID: 12559973 [TBL] [Abstract][Full Text] [Related]
11. CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolites. Ahlström MM; Ridderström M; Zamora I J Med Chem; 2007 Nov; 50(22):5382-91. PubMed ID: 17915853 [TBL] [Abstract][Full Text] [Related]
12. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis. Locuson CW; Wienkers LC; Jones JP; Tracy TS Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262 [TBL] [Abstract][Full Text] [Related]
13. Heteroactivator effects on the coupling and spin state equilibrium of CYP2C9. Locuson CW; Gannett PM; Tracy TS Arch Biochem Biophys; 2006 May; 449(1-2):115-29. PubMed ID: 16545770 [TBL] [Abstract][Full Text] [Related]
14. Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets. Polgár T; Menyhárd DK; Keseru GM J Comput Aided Mol Des; 2007 Sep; 21(9):539-48. PubMed ID: 17960328 [TBL] [Abstract][Full Text] [Related]
15. Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model. Hutzler JM; Hauer MJ; Tracy TS Drug Metab Dispos; 2001 Jul; 29(7):1029-34. PubMed ID: 11408370 [TBL] [Abstract][Full Text] [Related]
16. Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements. Hutzler JM; Kolwankar D; Hummel MA; Tracy TS Drug Metab Dispos; 2002 Nov; 30(11):1194-200. PubMed ID: 12386124 [TBL] [Abstract][Full Text] [Related]
17. Electrochemically driven drug metabolism via cytochrome P450 2C9 isozyme microsomes with cytochrome P450 reductase and indium tin oxide nanoparticle composites. Xu X; Wei W; Huang M; Yao L; Liu S Chem Commun (Camb); 2012 Aug; 48(63):7802-4. PubMed ID: 22743353 [TBL] [Abstract][Full Text] [Related]
18. Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19. Reynald RL; Sansen S; Stout CD; Johnson EF J Biol Chem; 2012 Dec; 287(53):44581-91. PubMed ID: 23118231 [TBL] [Abstract][Full Text] [Related]
19. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II. Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF Curr Drug Metab; 2009 Dec; 10(10):1127-50. PubMed ID: 20167000 [TBL] [Abstract][Full Text] [Related]
20. Enzyme source effects on CYP2C9 kinetics and inhibition. Kumar V; Rock DA; Warren CJ; Tracy TS; Wahlstrom JL Drug Metab Dispos; 2006 Nov; 34(11):1903-8. PubMed ID: 16928789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]